|
|
|
Insider
Information: |
Fuchs Henry J |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
222,228 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$18,063,061 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
222,228 |
|
|
Total
Value |
$18,063,061 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Onyx Pharmaceuticals Inc |
ONXX |
EVP & Chief Medical Of... |
2008-11-18 |
14,891 |
2006-05-15 |
0 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director |
2012-06-19 |
0 |
2007-12-05 |
0 |
Premium* |
|
Biomarin Pharmaceutical Inc |
BMRN |
President, Worldwide R&D |
2024-03-15 |
196,872 |
2009-03-02 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director |
2019-11-08 |
0 |
2014-04-01 |
0 |
Premium* |
|
Mirati Therapeutics, Inc. |
MRTX |
|
2023-01-20 |
10,465 |
2020-01-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
294 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 7 of 12
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2014-05-13 |
4 |
S |
$58.23 |
$83,498 |
D/D |
(1,434) |
64,850 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2014-05-13 |
4/A |
S |
$58.23 |
$83,498 |
D/D |
(1,434) |
63,415 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2012-01-03 |
4 |
AS |
$34.75 |
$86,883 |
D/D |
(2,500) |
36,611 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2014-05-12 |
4 |
D |
$59.30 |
$92,864 |
D/D |
(1,566) |
66,284 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
Director |
|
2010-01-11 |
4 |
AS |
$15.83 |
$94,954 |
D/D |
(6,000) |
10,416 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2019-02-25 |
4 |
OE |
$27.75 |
$97,708 |
D/D |
3,521 |
9,853 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2014-05-16 |
4 |
S |
$56.86 |
$105,994 |
D/D |
(1,864) |
60,950 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2019-03-01 |
4 |
D |
$94.76 |
$109,353 |
D/D |
(1,154) |
144,700 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2012-11-05 |
4 |
OE |
$11.05 |
$110,500 |
D/D |
10,000 |
62,277 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2013-05-22 |
4 |
OE |
$11.05 |
$110,500 |
D/D |
10,000 |
64,973 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2013-07-01 |
4 |
OE |
$11.05 |
$110,500 |
D/D |
10,000 |
53,266 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2013-09-05 |
4 |
OE |
$11.05 |
$110,500 |
D/D |
10,000 |
53,266 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2013-09-19 |
4 |
OE |
$11.05 |
$110,500 |
D/D |
10,000 |
53,266 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2013-03-01 |
4 |
D |
$59.61 |
$113,736 |
D/D |
(1,908) |
44,589 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2014-05-15 |
4 |
D |
$57.44 |
$116,948 |
D/D |
(2,036) |
62,814 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
|
2008-06-23 |
4 |
OE |
$21.01 |
$131,313 |
D/D |
6,250 |
23,225 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
|
2008-09-15 |
4 |
OE |
$21.01 |
$131,313 |
D/D |
6,250 |
22,183 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2010-04-01 |
4 |
S |
$24.00 |
$139,974 |
D/D |
(5,833) |
20,000 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2010-12-20 |
4 |
S |
$28.00 |
$140,000 |
D/D |
(5,000) |
31,000 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2014-05-08 |
4 |
D |
$56.78 |
$143,142 |
D/D |
(2,521) |
71,329 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2011-07-14 |
4 |
AS |
$30.00 |
$150,000 |
D/D |
(5,000) |
36,455 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2012-07-02 |
4 |
OE |
$11.05 |
$165,750 |
D/D |
15,000 |
67,277 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2016-05-13 |
4 |
D |
$82.71 |
$168,398 |
D/D |
(2,036) |
115,914 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2012-04-02 |
4 |
AS |
$34.08 |
$170,380 |
D/D |
(5,000) |
36,611 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2015-05-13 |
4 |
AS |
$121.37 |
$174,038 |
D/D |
(1,434) |
80,646 |
0 |
- |
|
294 Records found
|
|
Page 7 of 12 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|